Group One Trading’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
Group One Trading's TSHA Position: Q3 2026 in Review
Group One Trading increased its Taysha Gene Therapies (TSHA) stake by 3.5% in Q3 2026, buying an estimated $386 and bringing the position to 2,006 shares worth $9.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6329.
Group One Trading first reported a position in TSHA in Q4 2022 and has held it in 8 quarters since. The position peaked at $243K in Q4 2025. 205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.
- Group One Trading held 2,006 shares of Taysha Gene Therapies worth $9.8K as of Q3 2026.
- Group One Trading bought 67 Taysha Gene Therapies shares in Q3 2026, an estimated $386.
- Taysha Gene Therapies made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6329 holding.
- Group One Trading first reported a position in Taysha Gene Therapies in Q4 2022 and has held it in 8 quarters since.
- Group One Trading's Taysha Gene Therapies position peaked at $243K in Q4 2025.
- 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.